A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/26/2006	US20060241107 Androgen receptor modulators and methods of use thereof
10/26/2006	US20060241106 Isoxazole compounds as inhibitors of heat shock proteins
10/26/2006	US20060241104 Oxalamide derivatives as kinase inhibitors
10/26/2006	US20060241103 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
10/26/2006	US20060241102 Medicinal compositions
10/26/2006	US20060241101 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
10/26/2006	US20060241100 Acylaminobicyclic heteroaromatic compounds and uses thereof
10/26/2006	US20060241099 Use of 2-thia-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/26/2006	US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction
10/26/2006	US20060241095 complex comprising manganese acetate and {[{(Porphine-5,15-diyl)bis[cyclopropyl-diyl]}](2-)-N21,N22,N23, N24 }; reduce damage to cells; preventing or arresting free radical associated diseases or conditions; free radical scavengers
10/26/2006	US20060241094 Compositions that modulate the activity of estrogen receptors and estrogen-related receptors and methods for use
10/26/2006	US20060241093 Use of DHEA derivatives for enhancing physical performance
10/26/2006	US20060241092 Contraceptive regimens for lower-weight women
10/26/2006	US20060241091 Extended estrogen dosing contraceptive regimen
10/26/2006	US20060241090 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3
10/26/2006	US20060241089 Dipyridamole, acetylsalicylic acid, and angiotensin II antagonist pharmaceutical compositions
10/26/2006	US20060241088 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
10/26/2006	US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
10/26/2006	US20060241086 calcium salt of inositol tripyrophosphate; antihypoxic agent; cancer, stroke, alzheimer's
10/26/2006	US20060241085 Compounds having anti-proliferative properties
10/26/2006	US20060241084 Inhibition of vascular endothelial growth factor
10/26/2006	US20060241083 Novel heteroaryl phosphonates as cardioprotective agents
10/26/2006	US20060241082 Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease
10/26/2006	US20060241081 Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate
10/26/2006	US20060241080 Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
10/26/2006	US20060241079 Yeast extracts; promoting bone growth; suppressing osteoclast development while enhancing osteoblast formation; osteoporosis, Paget's disease; minimal side effects; reverse osmosis
10/26/2006	US20060241078 Pharmaceutical compositions comprising a contraceptive agent in solution and a teratogen
10/26/2006	US20060241077 Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
10/26/2006	US20060241074 Methods for treatment of pain
10/26/2006	US20060241070 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treament of cancer
10/26/2006	US20060241066 Decoy composition for treating and preventing inflammatory disease
10/26/2006	US20060241065 Ring-expanded nucleosides and nucleotides
10/26/2006	US20060241064 Nucleoside compounds for treating viral infections
10/26/2006	US20060241063 Novel uses of neuraminidase inhibitors in infectious diseases
10/26/2006	US20060241062 Method involving pde4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies
10/26/2006	US20060241061 Stable aqueous solution of natamycin fungicide
10/26/2006	US20060241060 10-Acetoxymethyl-2'O-acetyl-10,11-anhydro-10-desmethyl-6 O-methyl-descladinosyl-erythromycin A, for example; bactericides
10/26/2006	US20060241059 Treatments for viral infections
10/26/2006	US20060241058 Orally administered; paraesthesia or hyperaesthesia; non-insulin dependent diabetes
10/26/2006	US20060241057 provides compositions for inhibiting proteases, methods for synthesizing the compositions, and methods of using the disclosed protease inhibitors. Aspects of the disclosure include peptidyl allyl sulfone compositions that inhibit proteases, for example cysteine proteases, either in vivo or in vitro.
10/26/2006	US20060241052 Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
10/26/2006	US20060241045 Method for producing preparation containing bioactive substance
10/26/2006	US20060241037 Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
10/26/2006	US20060241036 Soluble human interleukin 18 receptor-alpha, method of assaying the same, assay kit and medicinal composition
10/26/2006	US20060241034 Means for preventing and treating cellular death and their biological applications
10/26/2006	US20060241023 Diabetic therapy; administering to patient an inhibitor of enzymatic conversion of fructose-lysine to fructose-lysine-3-phosphate
10/26/2006	US20060241021 Methods of treating cognitive dysfunction by modulating brain energy metabolism
10/26/2006	US20060240528 Polyketides and their synthesis
10/26/2006	US20060240475 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal
10/26/2006	US20060240410 Retroviral protease inhibitor combinations
10/26/2006	US20060240168 Chitosan foodstuff
10/26/2006	US20060240166 Modified acacia and use thereof
10/26/2006	US20060240131 Continuously or periodically administering human through inhalation a stress reactivity-reducing, tensive back, shoulder or neck muscle-relaxing period of time a stress reactivity-reducing, tensive back, stress reactivity-reducing shoulder or stress reactivity-reducing neck muscle-relaxing fragrance
10/26/2006	US20060240129 Skin tissue regeneration promoters comprising ginsenoside Rb1
10/26/2006	US20060240128 Combined immediate release and extended release analgesic composition
10/26/2006	US20060240127 Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
10/26/2006	US20060240125 Composition for affecting weight loss
10/26/2006	US20060240124 Treatment of anemia
10/26/2006	US20060240123 Pharmaceutical composition
10/26/2006	US20060240122 Antiseptic solutions containing silver chelated with polypectate and edta
10/26/2006	US20060240121 Chemotherapeutic composition using nanocrystalline calcium phosphate paste
10/26/2006	US20060240120 Composition for lowering blood glucose
10/26/2006	US20060240119 Pharmacologically active strong acid solutions
10/26/2006	US20060240118 Pharmacologically active strong acid solutions
10/26/2006	US20060240116 Bioactive factors in wound healing topical compositions and methods
10/26/2006	US20060240114 Drug for treating hemophilia and method of treating hemophilia using the same
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060240110 electrospun into fibers permitting immobilization and long-term delivery of biodrugs; compatibilizing polyoxyethylene glycol and low molecular weight heparin or heparin-binding peptide covalently attached
10/26/2006	US20060240108 Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
10/26/2006	US20060240106 Enteric coated composition comprising prostaglandin analogs as chloride channel opener
10/26/2006	US20060240105 Multiparticulate modified release composition
10/26/2006	US20060240103 Effervescent compositions comprising bisphosphonates and methods related thereto
10/26/2006	US20060240101 Orally disintegrating pharmaceutical tablet formulations of olanzapine
10/26/2006	US20060240100 Dosage form containing pantoprazole as active ingredient
10/26/2006	US20060240099 High-amylose starch
10/26/2006	US20060240097 (4-[((6E)-8-Methylnon-6-enoylamino)methyl]-2-methyoxyphenyl formate), for example; treatment of pain associated with postherpetic neuralgia, diabetic neuropathy, HIV-associated neuropathy, complex regional pain syndrome, cancer, nerve injury, cancer chemotherapy
10/26/2006	US20060240095 Pharmaceutical composition comprising a combination of metformin and a statin
10/26/2006	US20060240090 Combination compositions of camptothecins and fluoropyrimidines
10/26/2006	US20060240089 Use of pvp-iodine liposomes for treatment of herpes
10/26/2006	US20060240088 Caged ligands and uses thereof
10/26/2006	US20060240087 Composition and methods for drug delivery
10/26/2006	US20060240086 Adhesive patch
10/26/2006	US20060240085 Treatment of dependence withdrawal
10/26/2006	US20060240084 Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use
10/26/2006	US20060240077 Methodologies for improving the quality of meat, health status of animals and impact on environment
10/26/2006	US20060240075 Carnitine retention
10/26/2006	US20060240069 Catheter assembly with bactericidal effect
10/26/2006	US20060240066 Applying a formulation including a phenolic compound directly to connective tissue, the composition having a pH between about 4 and about 9, wherein the connective tissue comprises elastin and wherein the phenolic compound comprises a hydrophobic core that includes more than one phenolic group
10/26/2006	US20060240065 Compositions for medical devices containing agent combinations in controlled volumes
10/26/2006	US20060240064 Medical implants and fibrosis-inducing agents
10/26/2006	US20060240063 Medical implants and fibrosis-inducing agents
10/26/2006	US20060240059 Lubricious eluting polymer blend and coating made from the same
10/26/2006	US20060240056 Treatment of skin with adenosine or adenosine analog
10/26/2006	US20060240055 Perfume composition having sedative effect
10/26/2006	US20060240052 Ketoprofen compositions and methods of making them
10/26/2006	US20060240051 Eutectic blends containing a water soluble vitamin derivative
10/26/2006	US20060240050 Stable clozapine suspension formulation
10/26/2006	US20060240049 Anti-protozoal compositions comprising diclazuril
10/26/2006	US20060240047 Method for producing a vaccine for the treatment of cancer
10/26/2006	US20060240043 Methods and compositions for treating migraine pain

1 ... 4034 4035 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 4046 4047 4048 4049 4050 4051 4052 4053 4054 ... 7860